AB1584-PARE UNDERSTANDING HETEROGENEITY IN PATIENTS’ CONCEPTUALIZATION OF TREATMENT FOR RHEUMATOID ARTHRITIS: A CLUSTER ANALYSIS
Hsiao B, Downs J, Lanyon M, Curtis J, Blalock S, Wiedmeyer C, Venkatachalam S, Nowell W, Fraenkel L. AB1584-PARE UNDERSTANDING HETEROGENEITY IN PATIENTS’ CONCEPTUALIZATION OF TREATMENT FOR RHEUMATOID ARTHRITIS: A CLUSTER ANALYSIS. Annals Of The Rheumatic Diseases 2022, 81: 1890.2-1891. DOI: 10.1136/annrheumdis-2022-eular.2964.Peer-Reviewed Original ResearchRisk/benefit ratioRheumatoid arthritisGrant/research supportHigh-quality careDisease activityQuality careMean scoreBenefit ratioSystem-related barriersDepth patient interviewsCare/supportEli LillyQuality of careNon-Hispanic whitesRisk/benefitRatings of accessConceptualization of treatmentPhysician-patient relationshipTreatment escalationAntirheumatic drugsConclusions PatientsPoor adherenceSuboptimal carePatient interviewsDMARDs